Case Report| Volume 30, ISSUE 9, 105942, September 2021

Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy


      Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy.
      Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanical thrombectomy with complete recanalization and dramatically improved clinically. Positive detection of anti-PF4-heparin-antibodies confirmed vaccine-induced immune thrombotic thrombocytopenia diagnosis.
      In case of acute ischemic stroke after recent ChAdOx1 nCov-19 or Ad26.COV2.S vaccine, platelet count should be systematically checked before giving thrombolysis, and direct mechanical thrombectomy should be proposed in patients with large vessel occlusion.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Greinacher A.
        • Thiele T.
        • Warkentin T.E.
        • et al.
        Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.
        N Engl J Med. 2021; 21: 04840
        • Schultz N.H.
        • Sørvoll I.H.
        • Michelsen A.E.
        • et al.
        Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
        N Engl J Med. 2021; 21: 04882
        • Muir K.L.
        • Kallam A.
        • Koepsell S.A.
        • et al.
        Thrombotic thrombocytopenia after Ad26.COV2.S vaccination.
        N Engl J Med. 2021; 21: 05869
        • See I.
        • Su J.R.
        • Lale A.
        • et al.
        US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination.
        JAMA. 2021; 30 (Published online April)
        • Scully M.
        • Singh D.
        • Lown R.
        • et al.
        Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination.
        N Engl J Med. 2021; 21: 05385
        • Al-Mayhani T.
        • Saber S.
        • Stubbs M.J.
        • et al.
        Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia.
        J Neurol Neurosurg Psychiatry. 2021; 25 (Published online May)
        • Powers W.J.
        • Rabinstein A.A.
        • Ackerson T.
        • et al.
        Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2019; 50: 344-e418